Anthem Biosciences Limited (NSE:ANTHEM)
India · Delayed Price · Currency is INR 805.70
+4.95 (0.62%)
Oct 23, 2026, 3:29 PM IST
Anthem Biosciences Market Cap
Anthem Biosciences has a market cap or net worth of 453.77 billion as of October 22, 2026. It is the 3,705th most valuable company in the world and the 212th biggest in India. Its market cap has increased by 8.87% in one year.
Market Cap
453.77B
Enterprise Value
444.92B
Revenue
20.07B
Global Rank
Country Rank
#212 India
PE Ratio
79.71
ChartMarket Cap Chart
Since July 21, 2025, Anthem Biosciences's market cap has increased from 410.17B to 453.77B, an increase of 10.63%. That is a compound annual growth rate of 8.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 453.77B | 24.02% |
| Dec 31, 2025 | 365.89B | -10.80% |
| Jul 21, 2025 | 410.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biocon | 537.83B |
| OneSource Specialty Pharma | 157.63B |
| Concord Biotech | 132.55B |
| Blue Jet Healthcare | 92.17B |
| Supriya Lifescience | 67.30B |
| Zota Health Care | 44.15B |
| Dishman Carbogen Amcis | 21.99B |
| Panacea Biotec | 19.99B |